We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

67 hedge funds and large institutions have $165M invested in ANACOR PHARMACEUTICALS INC COM in 2013 Q2 according to their latest regulatory filings, with 67 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

14% less call options, than puts

Call options by funds: $131K | Put options by funds: $152K

Holders
67
Holders Change
+67
Holders Change %
% of All Funds
2.19%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
67
Increased
Reduced
Closed
Calls
$131K
Puts
$152K
Net Calls
-$21K
Net Calls Change
-$21K

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change
Change in
Stake
RCP
1
Rho Capital Partners
New York
$31.4M +$34M +5,621,423 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$29.4M +$31.9M +5,268,352 New
KCM
3
Kingdon Capital Management
New York
$10.9M +$11.9M +1,957,300 New
LOAMU
4
Lombard Odier Asset Management (USA)
New York
$10.7M +$11.6M +1,915,000 New
BC
5
Broadfin Capital
New York
$9.64M +$10.4M +1,724,028 New
PAI
6
Palo Alto Investors
California
$9.04M +$9.79M +1,617,651 New
VM
7
VHCP Management
New York
$9.01M +$9.75M +1,610,856 New
QF
8
QVT Financial
New York
$7.59M +$8.22M +1,358,303 New
BFA
9
BlackRock Fund Advisors
California
$5.62M +$6.08M +1,004,721 New
BBA
10
Baker Bros. Advisors
New York
$4.9M +$5.31M +876,463 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$3.9M +$4.23M +698,494 New
FCM
12
Farallon Capital Management
California
$3.56M +$3.86M +637,500 New
PA
13
Perceptive Advisors
New York
$3.26M +$3.53M +582,835 New
CCI
14
Columbus Circle Investors
$2.93M +$3.17M +524,315 New
IMOV
15
Investment Management of Virginia
Virginia
$2.88M +$3.12M +514,891 New
PWPCM
16
Perella Weinberg Partners Capital Management
New York
$2.57M +$2.79M +460,087 New
BIT
17
BlackRock Institutional Trust
California
$1.83M +$1.98M +327,456 New
Northern Trust
18
Northern Trust
Illinois
$1.53M +$1.65M +273,082 New
State Street
19
State Street
Massachusetts
$1.22M +$1.32M +218,594 New
TC
20
TFS Capital
Pennsylvania
$1.1M +$1.2M +197,440 New
BCM
21
Bridgeway Capital Management
Texas
$1.04M +$1.12M +185,300 New
T. Rowe Price Associates
22
T. Rowe Price Associates
Maryland
$907K +$982K +162,187 New
Geode Capital Management
23
Geode Capital Management
Massachusetts
$706K +$764K +126,249 New
U
24
UBS
Switzerland
$694K +$752K +124,200 New
USAA
25
United Services Automobile Association
Texas
$656K +$710K +117,300 New

ANAC Hedge Fund Activity: Q2 2013 in Review

67 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q2 2013, worth a combined $165M.

Buyers outnumbered sellers: 67 funds opened new ANAC positions and 0 closed out — a net gain of 67 holders — while 0 added to existing stakes and 0 trimmed.

  • 67 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $165M of ANACOR PHARMACEUTICALS INC COM stock for Q2 2013.
  • 67 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q2 2013 and 0 closed out, a net change of +67 holders.

Based on aggregated 13F filings for Q2 2013.